A/HRC/30/65
II. Right to health
A.
Access to treatment
6.
The right to health is provided for in article 12 of the International Covenant on
Economic Social and Cultural Rights. Under articles 2 (2) and 3 of the Covenant, States are
required to implement the right to health on a non-discriminatory basis, which includes
extending that right to drug users.
7.
The Special Rapporteur on the right to health has underlined the distinction between
drug use and drug dependence. Drug dependence is a chronic, relapsing disorder that
should be medically treated using a biopsychosocial approach. Drug use is neither a
medical condition nor does it necessarily lead to drug dependence. People who use drugs
and people who are dependent on drugs possess the same right to health as everyone else,
and those rights cannot be curtailed if the use of drugs constitutes a criminal offence (see
A/65/255, para. 7). The Special Rapporteur has noted that the same standards of ethical
treatment apply to the treatment of drug dependence as to other health-related conditions,
including with regard to the right of a patient to make decisions about treatment and to
refuse treatment.
8.
The Special Rapporteur has emphasized that health-care personnel have an
obligation to provide treatment on a non-discriminatory basis and not to stigmatize or
violate a patient’s human rights. Nevertheless, people who use drugs may be subject to
discrimination in health-care settings. People who inject drugs, for example, may have
poorer access to health care in some countries, including for the treatment of HIV/AIDS.
This may be due to unjustified restrictions by health-care providers on the provision of
heath care for people who inject drugs. 3 The Special Rapporteur noted that care providers
may not have adequate information or training concerning harm reduction measures (see
A/65/255, para. 46). The World Health Organization (WHO) has recommended training
health workers on issues of stigma and non-discrimination, to achieve better health
outcomes.4
9.
Individuals have sometimes been denied access to medical treatment on the grounds
of their prior or current drug use, where evidence does not justify denial of treatment. Such
denial has occurred on the rationale that a person’s drug use would make him or her unable
to adhere to treatment. The Special Rapporteur notes that adherence to medical treatment is
not necessarily lower among persons who use drugs, and should be assessed on an
individual basis (see A/65/255, paras 23-24).
10.
Outreach programmes are useful in providing information and referral health
services to drug users in the community. Information and education programmes can
minimize harm to individuals who use drugs and encourage drug dependent persons to seek
treatment.5
3
4
5
World Health Organization (WHO), United Nations Office on Drugs and Crime (UNODC) and Joint
United Nations Programme on HIV/AIDS (UNAIDS), Technical Guide for Countries to Set Targets
for Universal Access to HIV Prevention, Treatment and Care for Injecting Drug Users (2012), p. 26.
WHO, Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and Care for Key
Populations (July 2014), pp. 96-99.
Submission of the Special Rapporteur to the Committee against Torture (19 October 2012), p. 6.
Available from www.ohchr.org/Documents/Issues/Health/drugPolicyLaw.pdf.
3
Select target paragraph3
Connect to a paragraph
Connect to an entity
Disable highlights
Add to table of contents